Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.46B 1.28B 1.18B 1.09B 2.07B 139B 2.11B 14.16B 5.56B 68.44B 5.49B 5.37B 237B P/E 2026 *
28.9x
P/E 2027 * 15.7x
Enterprise Value 2.8B 2.46B 2.27B 2.09B 3.97B 267B 4.04B 27.12B 10.64B 131B 10.51B 10.28B 454B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.52x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day+2.18%
1 week+4.10%
Current month+4.62%
1 month+7.31%
3 months+89.80%
6 months+38.37%
Current year+51.29%
1 week 17.01
Extreme 17.01
18.86
1 month 17.01
Extreme 17.01
18.92
Current year 8.7
Extreme 8.7
18.92
1 year 8.7
Extreme 8.7
18.92
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
03/07Tax

Chief Financial Officer

-5,226 0.0067%
01/07Free

Executive/Senior Manager

11,180 0.0144%
01/07Free

Executive/Senior Manager

5,590 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+2.18%+4.10%+49.25%-54.50% 1.46B
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
-1.10%-3.29%+55.70%-5.76% 24.99B
0.00%-1.01%-5.28%-3.57% 21.05B
Average +0.73%-0.52%+9.24%-5.90% 53.47B
Weighted average by Cap. +0.51%-0.92%-5.44%+0.86%

Financials

2026 *2027 *
Net sales 1.68B 1.47B 1.36B 1.25B 2.37B 160B 2.42B 16.23B 6.37B 78.47B 6.29B 6.16B 272B 1.73B 1.52B 1.4B 1.29B 2.45B 165B 2.49B 16.76B 6.58B 81B 6.5B 6.35B 280B
Net income 42.73M 37.5M 34.61M 31.95M 60.54M 4.08B 61.58M 414M 162M 2B 160M 157M 6.92B 74.56M 65.43M 60.4M 55.75M 106M 7.11B 107M 722M 283M 3.49B 280M 274M 12.08B
Net Debt 1.34B 1.17B 1.08B 1B 1.9B 128B 1.93B 12.96B 5.09B 62.66B 5.02B 4.92B 217B 1.18B 1.03B 953M 879M 1.67B 112B 1.69B 11.39B 4.47B 55.06B 4.41B 4.32B 191B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
10/07/26 USD 18.79 +2.18% 951,869
09/07/26 USD 18.39 +6.30% 939,773
08/07/26 USD 17.30 -0.92% 702,386
07/07/26 USD 17.46 -3.96% 1,106,193
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
18.79USD
Average target price
18.00USD
Spread / Average Target
-4.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock